Sponsors
The Key to Increasing Diversity in Decentralized Trials
Rosamund Round VP of Parexel’s Patient Innovation Center and DCTs shares key strategies for increasing diversity in decentralized trials.
Unique Ethical Issues in Phase I Oncology Studies
An essential step in research, Phase I oncology studies raise unique ethical challenges for sponsors, investigators, and IRBs.
Returning to In-person Work: Sponsor Versus Site Viewpoints
An Advarra Trend Report found sites and sponsors alike are facing shifts as they continue to navigate the pandemic.
IRB Review of Phase I Healthy Research: Investigator and IRB Perspectives
Join our expert panel to learn about common pitfalls in Phase I study designs and IRB submissions and strategies to plan for success
Creating Opportunities for Inclusion, Diversity, Equity and Access In Clinical Research: A Discussion with Tiffany Danielle Pineda, Brian Sevier, and Wendy Tate
About the Advarra In Conversations With… The future of healthcare innovation hinges on research and clinical trials. Advarra sits down...
Decentralized Clinical Trials: Growing Trend? Tips and Best Practices for Sponsors/CROs
This webinar will present provide tips and best practices on the growing Decentralized Clinical Trials for Sponsors and CROs
The ROI of Site-Centric Training and Support
Download our white paper to learn how to maximize your research investment for site-centric training and support.
Maintaining Data & Reporting Integrity with Mobile Health
Understand how to properly handle and evaluate incoming data gathered using mobile health (mHealth) apps and technologies.
Integrating Expert Opinions: Why Your Clinical Trial Needs an EAC
In this webinar, we discuss the role of independent endpoint adjudication committees, from charter creation through end of study closeout.
Op-ed: Missing Elements of the Discussion on Decentralized Trials
Dr. Paul Evans, CEO of Velocity Clinical Research weighs in on what's missing in the discussion of decentralized trials.
Does This Study Require IBC Review?
While clinical research professionals are familiar with the role of the IRB to protect research subjects, most are unfamiliar with the added need for an Institutional Biosafety Committee (IBC).
Future of Work in Clinical Research
When SARS-CoV-2 (the virus causing the disease COVID-19) broke out in 2020, the clinical research community needed to pivot quickly...
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2025 Advarra. All Rights Reserved.